Agilent Technologies of Santa Clara, Calif., has received US Patent No. 8,530,157, "SNP-dependent end labeling method." The method includes contacting a genomic sample with a restriction endonuclease that recognizes a SNP site in the sample, in order to provide a digested genomic sample. The digested genomic sample is then contacted with an extension enzyme and a labeled nucleotide in order to produce a labeled sample.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.